Tuesday, January 26, 2021
Bacteriophage Market Analysis: To Reach Around US$ 567.9 Mn In 2027
Do you like this story?
The global bacteriophage market was valued at US$ 567.9 Mn in 2017 expanding at a CAGR of 3.9% from 2018 to 2026.
Market Insights
Recently, bacteriophages or phages have been recognized as an
efficient tool in modern biotechnology through a multitude of researches
promoting the potential use of bacteriophages across a number of applications.
Researchers have also proposed bacteriophages as a viable alternative to
antibiotics for a number of antibiotic-resistant bacterial strains. They can
also be used as biocontrol agents in the oil and agriculture industries.
Bacteriophages have a unique application in the petroleum
industry, as bacterial fouling often leads to serious damage to gas pipelines,
devaluing products and therefore increasing capital costs. In addition,
bacteriophages may also be used as vaccine vehicles, for the detection of
pathogenic bacterial strain, and as display systems (phage displays) for
several antibodies and proteins. Bacteriophages are a diverse group of viruses
that can be easily manipulated and therefore have a significant role to play in
research, therapeutics and biotechnology.
Phages not only control the bacterial population, but also help
to move genes from one bacterium to another. The Bacteriophage Particle Study
therefore provides insights into genome evolution, bacterial evolution, DNA
expression and copying, and thus the development of new biotechnology.
Globally, the incessant increase in bacterial resistance to most antibiotics is
becoming a new driving factor for phage therapy that uses lytic phage particles
because these entities are devoid of metabolic functioning and do not have an
affinity to eukaryotic cells. In addition, the use of bacteriophage particles
in phage vaccination is also emerging as one of the promising preventive
strategies currently under investigation. Bacteriophageal biosensing devices,
phage-display based selection of biological affinity molecules, food
biopreservation, food safety, biocontrol of plant pathogens, corrosion control
and biofilm control are also key areas for renewed focus.
Get Sample Copy of This Report With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/59356
Considering the product types, global bacteriophage market
categorized into ssDNA (single strand DNA) bacteriophage, dsDNA (double strand
DNA) bacteriophage and ssRNA (single strand RNA) bacteriophage. In 2017, dsDNA
bacteriophage occupied largest share in the global market, and anticipated to
continue its lead throughout the forecast period from 2018 to 2026. Majority of
the cultivated viruses that have potential in culminating the widest range of
bacteria are dsDNA, therefore dominating the global market. dsDNA bacteriophage
also have a wide applicability in phage display technologies.
In terms of geography, North America held the largest share in
the global bacteriophage market due to prominent phage entities in the U.S.,
faster and first in the world commercialization process in the region, and
significantly large patient pool suffering with bacterial infections and
growing incidence of anti-biotic resistance. Moreover, established use of
bacteriophages in the areas of environment and food and evolved research
infrastructure with several initiatives being undertaken introducing breakthrough
technologies will further drive the market during the forecast period. Asia
Pacific is projected to witness the fastest progress in the global market due
to rapidly evolving biotechnology infrastructure, evolving agriculture
practices, and equally supportive government initiatives. The key players
currently engaged in bacteriophage market include Federal State Scientific
Industrial Company MICROGEN, AmpliPhi Biosciences Corporation, EnBiotix, Phage
Biotech Ltd., Fixed-Phage Limited, InnoPhage, Pherecydes Pharma, TechnoPhage
SA, VersatileBio among others.
Key Market Movements:
• Growing R&D and funding for investigating bacteriophage
therapy for clinical application
• Ongoing clinical trials for bacteriophage therapy for multidrug resistant
bacterial infections and regulatory approvals for the same
• Increasing applications of bacteriophage in food, environment and veterinary
applications
• Ongoing research for establishing bacteriophage as an effective vaccine
delivery system
Get Sample Copy of This Report With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/59356
ToC:
Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation
Chapter 2. Executive Summary
2.1. Global Bacteriophage Market Portraiture
2.2. Global Bacteriophage Market, by Product Type, 2017 (US$ Mn)
2.3. Global Bacteriophage Market, by Application, 2017 (US$ Mn)
2.4. Global Bacteriophage Market, by Geography, 2017 (US$ Mn)
Chapter 3. Bacteriophage: Market Dynamics and Outlook
3.1. Market Overview
3.2. Drivers
3.2.1. Widening Application of Bacteriophages
3.2.2. Renewed Interest in Phage Therapy
3.3. Challenges
3.3.1. Significant Regulatory Challenges for Approval as an Alternative to
Antibiotics
3.4. Opportunities
3.4.1. Phage Particles as Vaccine Carriers
3.5. Attractive Investment Proposition, by Geography, 2017
3.6. Competitive Analysis: Global Bacteriophage Market, by Key Players, 2017
Chapter 4. Global Bacteriophage Market, by Product Type,
2016-2026 (US$ Mn)
4.1. Overview
4.2. dsDNA Bacteriophage
4.3. ssDNA Bacteriophage
4.4. ssRNA BActeriophage
Chapter 5. Global Bacteriophage Market, by Application,
2016-2026 (US$ Mn)
5.1. Overview
5.2. Clinical Application
5.3. Food & Beverages
5.4. Phage Display
5.5. Phage Therapy
5.6. Environmental Application
5.7. Veterinary
Chapter 6. Global Bacteriophage Market, by Geography, 2016 –
2026 (US$ Mn)
…………………..
Chapter 7. Company Profiles
…………….
Get Sample Copy of This Report With Covid19 Impact Analysis: https://www.credenceresearch.com/sample-request/59356
DoC: https://issuu.com/robsonspot/docs/bacteriophage_market.docx
About Us
Credence Research is a worldwide market research and counseling firm that
serves driving organizations, governments, non-legislative associations, and
not-for-benefits. We offer our customers some assistance with making enduring
enhancements to their execution and understand their most imperative
objectives.
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
(US/CANADA) Ph.: +1-800-361-8290
E-mail: sales@credenceresearch.com
0 Responses to “Bacteriophage Market Analysis: To Reach Around US$ 567.9 Mn In 2027”
Post a Comment